Gene-delivery systems using cationic polymersGARNETT, M. C.Critical reviews in therapeutic drug carrier systems. 1999, Vol 16, Num 2, pp 147-207, issn 0743-4863Article

Uptake and metabolism of novel biodegradable poly(glycerol-adipate) nanoparticles in DAOY monolayerMENG, W; PARKER, T. L; KALLINTERI, P et al.Journal of controlled release. 2006, Vol 116, Num 3, pp 314-321, issn 0168-3659, 8 p.Article

In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheresNEAL, J. C; STOLNIK, S; SCHACHT, E et al.Journal of pharmaceutical sciences. 1998, Vol 87, Num 10, pp 1242-1248, issn 0022-3549Article

Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targetingEMBLETON, M. J; HABIB, N. A; GARNETT, M. C et al.International journal of cancer. 1986, Vol 38, Num 6, pp 821-827, issn 0020-7136Article

Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targetingEMBLETON, M. J; HABIB, N. A; GARNETT, M. C et al.International journal of cancer. 1986, Vol 38, Num 6, pp 821-827, issn 0020-7136Article

Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacersFITZPATRICK, J. J; GARNETT, M. C.Anti-cancer drug design. 1995, Vol 10, Num 1, pp 1-9, issn 0266-9536Article

Estimation of the poly(ethylene glycol) chain length of L-polylactide-polyethylene glycol in aqueous dispersions using viscoelastic measurementsHAGAN, S. A; DAVIS, S. S; ILLUM, L et al.Langmuir. 1995, Vol 11, Num 5, pp 1482-1485, issn 0743-7463Article

Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymersSTOLNIK, S; DUNN, S. E; ILLUM, L et al.Pharmaceutical research. 1994, Vol 11, Num 12, pp 1800-1808, issn 0724-8741Article

Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studiesHENN, T. F. G; GARNETT, M. C; SIRI RAM CHHABRA et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 11, pp 1570-1579, issn 0022-2623Article

Studies on the mechanism of action of an MTX-HSA-MoAb conjugateFITZPATRICK, J. J; GARNETT, M. C.Anti-cancer drug design. 1995, Vol 10, Num 1, pp 11-24, issn 0266-9536Article

Mouse IgG2b monoclonal antibody fragmentation: preparation and purification of Fab, Fc and Fab/c fragmentsDEMIGNOT, S; GARNETT, M. C; BALDWIN, R. W et al.Journal of immunological methods. 1989, Vol 121, Num 2, pp 209-217, issn 0022-1759Article

Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugatesGARNETT, M. C; BALDWIN, R. W.European journal of cell biology. 1986, Vol 41, Num 2, pp 214-221, issn 0171-9335Article

Preparation and in vitro characterization of HSA-mPEG nanoparticlesWU LIN; GARNETT, M. C; SCHACHT, E et al.International journal of pharmaceutics. 1999, Vol 189, Num 2, pp 161-170, issn 0378-5173Article

Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agentWU LIN; COOMBES, E. G. A; GARNETT, M. C et al.Pharmaceutical research. 1994, Vol 11, Num 11, pp 1588-1592, issn 0724-8741Article

Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodiesGOTTSCHALK, U; GARNETT, M. C; WARD, R. K et al.Journal of antibiotics (Tokyo. 1968). 1991, Vol 44, Num 10, pp 1148-1154, issn 0021-8820Article

Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheresNEAL, J. C; STOLNIK, S; GARNETT, M. C et al.Pharmaceutical research. 1998, Vol 15, Num 2, pp 318-324, issn 0724-8741Article

Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymerVANDORPE, J; SCHACHT, E; DUNN, S et al.Biomaterials. 1997, Vol 18, Num 17, pp 1147-1152, issn 0142-9612Article

Poly(organo phosphazene) nanoparticles surface modified with poly(ethylene oxide)VANDORPE, J; SCHACHT, E; STOLNIK, S et al.Biotechnology and bioengineering. 1996, Vol 52, Num 1, pp 89-95, issn 0006-3592Conference Paper

Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic actionBYERS, V. S; PAWLUCZYK, I. Z. A; HOOI, D. S. W et al.Cancer research (Baltimore). 1991, Vol 51, Num 8, pp 1990-1995, issn 0008-5472, 6 p.Article

Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugatesDURRANT, L. G; GARNETT, M. C; GALLEGO, J et al.British journal of cancer. 1987, Vol 56, Num 6, pp 722-726, issn 0007-0920Article